Pharmaceuticals

Neuroregeneration Therapy Market Forecast: What to Expect by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Neuroregeneration Therapy Market Between 2025 And 2029?

The neuroregeneration therapy market has experienced substantial expansion in recent years. It is projected to increase from $9.98 billion in 2024 to $11.29 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.1%. The growth observed in the historic period can be attributed to a combination of factors, including the increasing prevalence of neurological disorders, a rising global geriatric population, growing investments in research and development, increasing government support and funding, and rising collaborations between academia and industry.

The neuroregeneration therapy market is set for significant expansion in the upcoming years, with projections indicating a rise to $18.23 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.7%. This forecasted growth is largely driven by factors such as the escalating demand for neuroregeneration treatments, the increasing need for cell therapies, evolving healthcare requirements, augmented investments in biotechnology, and an expanding aging population. Prominent trends expected in this period include advancements in stem cell-based treatments, the progression of personalized medicine, innovations in gene editing for neurodegenerative conditions, the use of nanotechnology in drug delivery systems, and the growth of pharma-biotech collaborations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27358&type=smp

Which Drivers Are Impacting The Neuroregeneration Therapy Market?

The neuroregeneration therapy market is anticipated to expand due to the increasing incidence of neurological disorders. These conditions, which disrupt the normal functioning of the nervous system, affect the brain, spinal cord, or peripheral nerves. The rise in neurological disorders is linked to exposure to environmental toxins; for example, prolonged contact with pollutants like heavy metals, pesticides, and industrial chemicals can harm the nervous system and increase the likelihood of developing neurodegenerative diseases. Neuroregeneration therapy addresses these disorders by mending or replacing damaged neurons and tissues, thereby restoring lost functions and encouraging healing within the brain, spinal cord, or nerves to enhance mobility, sensation, and overall quality of life. As reported in October 2023 by the World Federation of Neurology, a UK-based association of national neurological societies, over 40% of the global population currently suffers from some form of neurological condition, a burden projected to nearly double by 2050. Consequently, the growing prevalence of neurological disorders is a significant factor driving the neuroregeneration therapy market. The expanding elderly demographic is projected to boost the neuroregeneration therapy market moving forward. An aging population signifies a demographic shift characterized by an increased proportion of older individuals within society, presenting potential societal and economic challenges. This demographic growth primarily stems from longer life expectancies, a result of improvements in healthcare and living standards, leading to a greater number of elderly people. Neuroregeneration therapy assists the aging population by repairing compromised nerve cells to improve brain function and mobility, while also retarding cognitive decline to enhance the quality of life for those with neurological conditions. For instance, according to the House of Commons Library, a UK-based library and information resource of the lower house of the British Parliament, in July 2024, the population aged 65 and over accounted for approximately 19% of the UK’s total population in 2022, totaling around 12.7 million individuals. This segment is expected to increase substantially, reaching 22.1 million and making up 27% of the population by 2072. Thus, the increasing aging population is a key driver for the neuroregeneration therapy market.

How Is The Neuroregeneration Therapy Market Classified Into Different Segments?

The neuroregeneration therapy market covered in this report is segmented

1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Other Types Of Neuroregeneration Therapy

2) By Technology: Tissue Engineering, Cranial And Spinal Stimulation, Nanotechnology In Drug Delivery, Biomaterials Development

3) By Mode Of Administration: Oral, Injectable, Implantable, Other Modes Of Administration

4) By Indication: Spinal Cord Injury, Traumatic Brain Injury, Stroke, Parkinson’s Disease, Multiple Sclerosis, Alzheimer’s Disease, Peripheral Nerve Injury, Other Indications

5) By End-User: Hospitals, Clinical Research Institutes, Academic Institutions, Pharmaceutical And Biotechnology Companies

Subsegment:

1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Neural Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Hematopoietic Stem Cell Therapy

2) By Gene Therapy: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector Based Gene Therapy, Non Viral Vector Based Gene Therapy, Genome Editing Gene Therapy

3) By Pharmacological Therapy: Neuroprotective Drugs, Neurotrophic Factor Based Drugs, Anti Inflammatory Drugs, Antioxidant Drugs, Cholinesterase Inhibitors

4) By Neurostimulation Therapy: Deep Brain Stimulation, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Transcranial Direct Current Stimulation

5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy, Exosome Based Therapy, Biomaterial Based Therapy, Electromagnetic Field Therapy, Hyperbaric Oxygen Therapy

How Are Trends Influencing The Neuroregeneration Therapy Market?

Leading companies in the neuroregeneration therapy market are concentrating on developing advanced products, such as resorbable implants, to improve nerve regeneration by supporting axonal growth and enhancing clinical outcomes in peripheral nerve repair. A resorbable implant is a medical device designed to gradually dissolve and be absorbed by the body after serving its purpose, eliminating the need for surgical removal. For instance, in March 2022, Integra LifeSciences Holdings Corporation, a US-based biotechnology company, launched the NeuraGen 3D Nerve Guide Matrix, which is designed for the repair of peripheral nerve discontinuities. The product was engineered to create an optimized environment for nerve healing by combining Integra’s bovine type 1 collagen and an innovative inner matrix with porous channels, which guides Schwann cell migration and directs axonal growth. This launch represented a significant advancement in peripheral nerve repair, offering surgeons a new solution for short- to mid-gap nerve repairs, and was the culmination of years of research and technological collaboration focused on improving patient functional recovery after nerve injuries.

Who Are The Core Companies Influencing The Neuroregeneration Therapy Market Landscape?

Major companies operating in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neuroregeneration-therapy-global-market-report

What Are The Key Regional Factors Influencing The Neuroregeneration Therapy Market Growth?

North America was the largest region in the neuroregeneration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroregeneration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neuroregeneration Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27358&type=smp

Browse Through More Reports Similar to the Global Neuroregeneration Therapy Market 2025, By The Business Research Company

Construction Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/construction-plastics-global-market-report

Wood Plastic Composite Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wood-plastic-composite-global-market-report

Plastic Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plastic-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795